Daniel Burgess
Chairman chez NABRIVA THERAPEUTICS PLC
Fortune : 3 349 $ au 31/03/2024
Profil
Daniel D.
Burgess was the founder of Rempex Pharmaceuticals, Inc. (founded in 2011) where he held the title of President, Chief Executive Officer & Director from 2011 to 2013.
He is currently the Chairman & Chief Executive Officer of Pulmocide Ltd.
and Chairman of BIOCOM (from 2017 to 2019).
He is also the Chairman of Cidara Therapeutics, Inc., Nabriva Therapeutics Plc, Qpex Biopharma, Inc., and an Independent Director of Arbutus Biopharma Corp.
He serves as a Director of Leiter's Enterprises, Inc., Leiters, Inc., and Therini Bio, Inc. (since 2021).
Mr. Burgess previously held the position of President & Chief Executive Officer of MPEX Pharmaceuticals, Inc. (from 2007 to 2011) and Chairman-Supervisory Board of Nabriva Therapeutics GmbH (from 2016 to 2017).
He has also served as Chairman of Atox Bio Ltd.
and as an Independent Director of Santarus, Inc. (from 2011 to 2014).
Additionally, he was a Director of Metabasis Therapeutics, Inc., Arsanis, Inc., Avalyn Pharma, Inc., and Castle & Cooke, Inc. Mr. Burgess has a background in finance and was previously the Chief Operating & Financial Officer of Harbor Diversified, Inc. (from 1999 to 2007) and the Chief Financial Officer & Vice President of Ngen, Inc. (from 1998 to 2007).
He has also held positions at SICOR, Inc., SV Health Investors LLC, Smith Barney Harris Upham & Co., Inc., Gensia Automedics, Inc., and Hollis Eden Pharmaceuticals.
Mr. Burgess completed his undergraduate studies at Stanford University and holds an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/02/2024 | 3 000 ( 0,00% ) | 2 760 $ | 31/03/2024 | |
NABRIVA THERAPEUTICS PLC
0,01% | 31/01/2023 | 415 ( 0,01% ) | 589 $ | 31/07/2023 |
| 24/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Daniel Burgess
| Sociétés | Poste | Début |
|---|---|---|
| CIDARA THERAPEUTICS, INC. | Chairman | - |
| ARBUTUS BIOPHARMA CORPORATION | Director/Board Member | 23/03/2017 |
| NABRIVA THERAPEUTICS PLC | Chairman | 23/06/2017 |
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Director/Board Member | 01/05/2019 |
Leiters, Inc.
 Leiters, Inc. Pharmaceuticals: MajorHealth Technology Leiters, Inc. manufactures sterile drug compounds. The private company is based in Fort Lauderdale. | Director/Board Member | - |
Qpex Biopharma, Inc.
 Qpex Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Qpex Biopharma, Inc. develops a pipeline of agents addressing critical needs for the treatment of infectious diseases in the inpatient and outpatient settings. The company is headquartered in San Diego, CA. | Chairman | - |
Leiter's Enterprises, Inc.
 Leiter's Enterprises, Inc. Pharmaceuticals: MajorHealth Technology Leiter's Enterprises, Inc. provides ophthalmology and hospital-based services. It develops ophthalmic sterile injectables, sterile eye drops, non-sterile eye drops and trimix intracavernosal injections. The company was founded in 1925 and is headquartered in San Jose, CA. | Director/Board Member | - |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Chief Executive Officer | - |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Director/Board Member | 26/02/2019 |
Anciens postes connus de Daniel Burgess
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Daniel Burgess
| Stanford University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| HARBOR DIVERSIFIED, INC. | Health Technology |
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| CIDARA THERAPEUTICS, INC. | Health Technology |
| NABRIVA THERAPEUTICS PLC | Health Technology |
| Entreprise privées | 21 |
|---|---|
Castle & Cooke, Inc.
 Castle & Cooke, Inc. HomebuildingConsumer Durables Castle & Cooke, Inc. owns and develops real estate, leases transportation equipment and manufactures brick. The firm conducts residential real estate development operations in Hawaii, Bakersfield, California, Sierra Vista, Arizona and Florida. The company was founded by Samuel Northrup Castle and Amos Starr Cooke on June 2, 1851 and is headquartered in Los Angeles, CA. | Consumer Durables |
Ngen, Inc.
 Ngen, Inc. Medical SpecialtiesHealth Technology Ngen, Inc. advanced diagnostics provides physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and reliable NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop diagnostic tests for variety of diseases. Nanogen also offers a broad portfolio of patented nucleic acids chemistries and molecular tools that accelerate genomic analysis and are compatible with many systems. The SynX subsidiary offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. The company is headquartered in San Diego, CA | Health Technology |
SICOR, Inc.
 SICOR, Inc. Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., SICOR, Inc. is a private company that manufactures pharmaceuticals. The company is based in San Diego, CA. The company was founded by Harry E. Gruber, Jack W. Reich, Paul K. Laikind, Robert L. Engler. SICOR was acquired by Teva Pharmaceutical Industries Ltd. on January 22, 2004 for $3,297.10 million. | Health Technology |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Health Technology |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Health Technology |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
Avalyn Pharma, Inc.
 Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | Health Technology |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Finance |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
| Smith Barney Harris Upham & Co., Inc. | Finance |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Health Technology |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Commercial Services |
| Gensia Automedics, Inc. | |
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Health Technology |
Rempex Pharmaceuticals, Inc.
 Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Health Technology |
Pulmocide Ltd.
Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Health Technology |
Leiter's Enterprises, Inc.
Leiter's Enterprises, Inc. Pharmaceuticals: MajorHealth Technology Leiter's Enterprises, Inc. provides ophthalmology and hospital-based services. It develops ophthalmic sterile injectables, sterile eye drops, non-sterile eye drops and trimix intracavernosal injections. The company was founded in 1925 and is headquartered in San Jose, CA. | Health Technology |
Qpex Biopharma, Inc.
Qpex Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Qpex Biopharma, Inc. develops a pipeline of agents addressing critical needs for the treatment of infectious diseases in the inpatient and outpatient settings. The company is headquartered in San Diego, CA. | Health Technology |
Leiters, Inc.
Leiters, Inc. Pharmaceuticals: MajorHealth Technology Leiters, Inc. manufactures sterile drug compounds. The private company is based in Fort Lauderdale. | Health Technology |
Therini Bio, Inc.
Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Commercial Services |
Hollis Eden Pharmaceuticals
 Hollis Eden Pharmaceuticals Pharmaceuticals: MajorHealth Technology Hollis Eden Pharmaceuticals is a private company that focuses on researching and developing drugs for adrenal steroid hormones. The company is based in San Diego, CA. | Health Technology |
